A detailed history of Abich Financial Wealth Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 187 shares of BEAM stock, worth $4,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
187
Previous 74 152.7%
Holding current value
$4,880
Previous $1.73 Million 164.24%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$22.57 - $33.14 $2,550 - $3,744
113 Added 152.7%
187 $4.58 Million
Q2 2024

Aug 14, 2024

BUY
$21.22 - $32.66 $1,188 - $1,828
56 Added 311.11%
74 $1.73 Million
Q1 2024

Jun 21, 2024

BUY
$23.46 - $45.07 $93 - $180
4 Added 28.57%
18 $595,000
Q4 2023

Feb 13, 2024

BUY
$17.69 - $30.76 $247 - $430
14 New
14 $381,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.84B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Abich Financial Wealth Management LLC Portfolio

Follow Abich Financial Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abich Financial Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abich Financial Wealth Management LLC with notifications on news.